aceRNA Technologies Co., Ltd. is a biotech startup established in 2018 based on RNA design technology developed in synthetic RNA biology research by Prof. Hirohide Saito at Kyoto University. We are developing "smart gene therapy” (mRNA-based and virus-base) that enables control of therapeutic transgene expression in cell-type and -state specific manner. By that, we are committed to develop new therapeutic approach, such as in vivo cell programming.
| Website | https://acernatec.com/en/ |
| Employees | 6 (4 on RocketReach) |
| Founded | 2018 |
| Industry | Biotechnology Research |
| Keywords | Therapeutics, Rna Therapeutics, Gene Therapy, Mrna Technology, Synthetic Biology, Drug Delivery, Biotechnology, Pharmaceutical, Molecular Biology, Genetic Engineering, Rna Modification, Gene Editing, Viral Vectors, Oligonucleotides, Precision Medicine, Biopharma, Life Sciences, Clinical Trials |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, QIAGEN, Bio-Rad Laboratories, PerkinElmer, Inc., MilliporeSigma, Roche, Promega Corporation, NanoString Technologies, Inc. +38 more (view full list) |
Looking for a particular aceRNA Technologies employee's phone or email?
aceRNA Technologies Questions
Fumihiro Sugawa is the President and CEO of aceRNA Technologies.
4 people are employed at aceRNA Technologies.
Top aceRNA Technologies Employees
G2Crowd Trusted
300K+
Plugin Users
